Achieve Life Sciences, Inc.
ACHV· Nasdaq
Filed Mar 26, 2015 · 10-K · 85 days after period end · 0001564590-15-002010
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Net Income | -$5.68M | -$6.68M | -$4.10M | -$9.57M |
| EPS Diluted | -$0.26 | -$0.45 | -$0.28 | -$0.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 26, 2015 · 85 d after period end